FDA Orange Book · active-ingredient family
Dextromethorphan hydrobromide; quinidine sulfate
Dextromethorphan hydrobromide; quinidine sulfate is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:NUEDEXTA · NDA 021879
1
Brand (NDA)
3
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NUEDEXTARLD | OTSUKA AMERICA PHARM | NDA 021879 | AB | Oct 29, 2010 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | SUN PHARM | ANDA 204196 | AB | Jun 03, 2026 | |
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | HETERO LABS LTD III | ANDA 218426 | AB | Aug 28, 2024 | |
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | ACTAVIS ELIZABETH | ANDA 202934 | AB | Oct 10, 2017 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7659282 | Aug 13, 2026 | in 2 mo | U-1093 |
Dextromethorphan hydrobromide; quinidine sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

